CASI PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2022 FINANCIAL RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
CASI Pharma (CASI) Tops Q1 EPS by 3c
May 12, 2022 7:10 AM EDTCASI Pharma (NASDAQ: CASI) reported Q1 EPS of ($0.06), $0.03 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $9 million versus the consensus estimate of $9.23 million.
For earnings history and earnings-related data on CASI Pharma (CASI) click here.
... More